Sentence examples for between the two combinations from inspiring English sources

Although the results from ((omega _{{mathrm{Frag}}}), (omega _{{mathrm{RT}}}), (omega _{{mathrm{Refs}}} in {0,1})) above indicated that the term (S_{C_{{mathrm{CRC + CERC + CDC}}}}) yielded the best result for ChemSpider with 411 top 1 ranks, (S_{C_{{mathrm{CRC}}}}) yielded 410 top 1 ranks for the same calculations, indicating that there is little difference between the two combinations.

However, the numbers of detected jiDE genes were different between the two combinations.

A total of two adenoma patients overlapped between the two combinations.

A major difference between the two combinations is that the latter is heterozygous for the skl locus.

At the end of the study no differences were observed between the two combinations on metabolic improvement and reduction in Hcy levels, while reduction in Lp- a) was observed onLp- a the pioglitazone/metformin group (Derosa et al. 2006b).

The ranges of values were similar for the fixed and non-fixed combination, and changes went both ways between the two combinations: for DHA and DEAQ, values increased in 46 and 35% of patients, respectively, and decreased in 54 and 65%, respectively.

46 BPO/clin was more efficacious than BPO monotherapy for reducing inflammatory lesions, and there was no difference in efficacy between the two combination therapies.

52 Finally, a recently published study of the combination of pioglitazone and sibutramine in type 2 diabetes patients intolerant to metformin and treated with sibutramine has shown a substantial equivalence in efficacy and tolerability between the two combination treatments.

Randomised clinical trials comparing the combination of paclitaxel with either cisplatin or with carboplatin in patients with advanced-stage OVCA found no significant differences in efficacy between the two combination treatments, although there was generally an improved tolerability for the carboplatin-containing regimen (Neijt et al, 2000; du Bois et al, 2003; Ozols et al, 2003).

As previously discussed, Leyden et al compared BPO/clin (5%/1%) vs BPO (5%) or BPO/erythro (5%/3%) in a 10-week study of 492 patients, showing no differences between the two combination therapies, however BPO/erythro was more efficacious than BPO alone.

This indicates that the mean differences between the eight combinations are not statistically significant at a significance level of.05.